Amedeo Smart

Free Medical Literature Service



Gastric Cancer

  Free Subscription

Articles published in
    July 2021
  1. JANJIGIAN YY, Shitara K, Moehler M, Garrido M, et al
    First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
    Lancet. 2021;398:27-40.
    >> Share

    August 2020
  2. SMYTH EC, Nilsson M, Grabsch HI, van Grieken NC, et al
    Gastric cancer.
    Lancet. 2020;396:635-648.
    >> Share

    January 2020
  3. AL-BATRAN SE, Pauligk C, Gotze TO
    Perioperative chemotherapy for gastric cancer in FLOT4 - Authors' reply.
    Lancet. 2020;395:e4.
    >> Share

  4. ROVIELLO G, Roviello F, Mini E
    Perioperative chemotherapy for gastric cancer in FLOT4.
    Lancet. 2020;395:e3.
    >> Share

  5. JAIN A
    Perioperative chemotherapy for gastric cancer in FLOT4.
    Lancet. 2020;395:e2.
    >> Share

    May 2019
  6. AL-BATRAN SE, Homann N, Pauligk C, Goetze TO, et al
    Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4):
    Lancet. 2019;393:1948-1957.
    >> Share

    April 2019
  7. KANG YK, Cho H
    Perioperative FLOT: new standard for gastric cancer?
    Lancet. 2019 Apr 10. pii: S0140-6736(18)33189.
    >> Share

    September 2018
  8. LIU JW, Ma DL
    An ominous sign from Sister Mary Joseph.
    Lancet. 2018;392:776.
    >> Share

    July 2018
  9. SMYTH EC, Petty RD
    Pembrolizumab versus paclitaxel in gastro-oesophageal adenocarcinoma.
    Lancet. 2018;392:97-98.
    >> Share

  10. SHITARA K, Ozguroglu M, Bang YJ, Di Bartolomeo M, et al
    Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
    Lancet. 2018;392:123-133.
    >> Share

    October 2017
  11. CHAU I
    Checkpoint inhibition: an ATTRACTION in advanced gastric cancer?
    Lancet. 2017 Oct 5. pii: S0140-6736(17)32131.
    >> Share

    November 2016
  12. ZONG L, Abe M, Seto Y, Ji J, et al
    The challenge of screening for early gastric cancer in China.
    Lancet. 2016;388:2606.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016